Important clinical factors in sequential therapy including lenvatinib against unresectable hepatocellular carcinoma

Atsushi Hiraoka*, Takashi Kumada, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Toshifumi Tada, Hidenori Toyoda, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Korenobu HayamaMichitaka Imai, Kouji Joko, Hironori Tanaka, Tsutomu Tamai, Yohei Koizumi, Yoichi Hiasa, Kojiro Michitaka, Masatoshi Kudo

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Important clinical factors in sequential therapy including lenvatinib against unresectable hepatocellular carcinoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science